The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

British scientists have hailed the US approval of a new drug for schizophrenia, saying it “has the potential to change the ...

FARGO, N.D. (Valley News Live) - Changes are coming to the way schizophrenia is treated. The US Food and Drug Administration ...

The FDA has approved Bristol Myers Squibb’s new schizophrenia drug, Cobenfy, the first novel treatment for schizophrenia in over 70 years. Schizophrenia affects nearly 3 million U.S. adults, but only ...

Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer ...

London: Neurocrine Biosciences said on Thursday it will halt the development of its experimental drug, aimed at improving cognitive function in patients with schizophrenia, after it did not ...

A Coventry shop has relocated ahead of the multi-million-pound regeneration project City Centre South. Max Mobility has opened at Lower Precinct Shopping Centre. Max Mobility was previously ...

A Coventry burglary who raided a home in Corley was caught after forensics linked him to the break-in. Police say that Jamie Poultney, aged 38, of Bridgecote, broke into a house and stole a number ...

Neurocrine said it will focus its resources on late-stage development of its other schizophrenia and depression drug candidates. Shares of the company were down 2.5% in extended trading.